Introduction
This policy fully supports the recommendations for clinical practice & training in transfusion medicine published by the National Institute of Health & Care Excellence (NICE), British Society for Haematology (BSH), the National Blood Transfusion Committee (NBTC), the Serious Hazards of Transfusion (SHOT) scheme & other national / local guidelines as referenced. This policy encompasses all blood components / products & has appendices covering guidance on specific issues as listed in the contents page.
Ashford & St Peters NHS Foundation Trust is committed to the provision of a service that is fair, accessible & meets the needs of all individuals.
Scope of the Policy
All staff involved in sampling, prescribing, ordering, collecting, administration of blood components / products & care/monitoring of a patient receiving a transfusion must read the sections relevant to their place of work & role.
This policy applies to adult patients at Ashford and St Peters Hospitals NHS Foundation Trust & the satellite hospitals that use blood components/products supplied by the Transfusion Laboratories.
Appendices
- Appendix 3: Indication for RBC, PLT, FFP and CRYO
- Appendix 4: Transfusion Associated Circulatory Overload
- Appendix 5: Specific requirements for blood components
- Appendix 6: Storage of blood and blood components
- Appendix 7: Blood collection process
- Appendix 8: Acute transfusion reaction management
- Appendix 9: Transferring a patient having transfusion or who may need blood in transit form (external transfer)
- Appendix 10: Tranexamic Acid
- Appendix 11: Abbreviations
Policy Details
Download: | PDF version |
Compiled by: | Kim East, Lead Transfusion Practitioner Matthew Rogers, BSPS Lead for Transfusion Consultant Haematologist |
Ratified by: | ASPH Patient Blood Management Committee BSPS Joint Patient Blood Management Team |
Date Ratified: | April 2023 |
Date Issued: | July 2023 |
Review Date: | April 2025 |
Target Audience: | All staff involved with blood transfusion and any associated blood products including anti-D and Beriplex. |
Contact name: | Kim East, Matthew Rogers |